• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人乳腺癌组织中雌激素受体检测方法的评估

Evaluation of estrogen receptor assays in human breast cancer tissue.

作者信息

McGuire W L, De La Garza M, Chamness G C

出版信息

Cancer Res. 1977 Mar;37(3):637-9.

PMID:837364
Abstract

Standard dextran-coated charcoal (DCC) and sucrose gradient centrifugation assays for estrogen receptor were compared in a series of human breast cancer tissues. From a quantitative standpoint the results were remarkably similar. A simplified version of the DCC assay compared to the sucrose gradient assay yielded acceptable results. We conclude that, in spite of the lack of specificity controls inherent in the sophisticated standard assays, the simplified DCC assay might be useful if the biopsy specimen is too small to provide the number of aliquots for a standard DCC assay or sufficient protein for a sucrose gradient analysis. It also might be useful in research laboratories attempting to develop assays for multiple receptors or other constituents in a single tumor biopsy specimen.

摘要

在一系列人类乳腺癌组织中,对用于雌激素受体检测的标准葡聚糖包被活性炭(DCC)法和蔗糖密度梯度离心法进行了比较。从定量角度来看,结果非常相似。与蔗糖密度梯度法相比,DCC法的简化版本也能得出可接受的结果。我们得出结论,尽管复杂的标准检测方法本身缺乏特异性对照,但如果活检标本太小,无法提供用于标准DCC检测的等分试样数量,或者无法提供用于蔗糖密度梯度分析的足够蛋白质,那么简化的DCC检测方法可能会有用。它在试图针对单个肿瘤活检标本开发多种受体或其他成分检测方法的研究实验室中可能也很有用。

相似文献

1
Evaluation of estrogen receptor assays in human breast cancer tissue.人乳腺癌组织中雌激素受体检测方法的评估
Cancer Res. 1977 Mar;37(3):637-9.
2
[Comparative studies of estrogen receptor determinations by enzyme immuno-assay using the monoclonal antibody, dextran-coated charcoal, and sucrose density gradient methods].
Gan To Kagaku Ryoho. 1985 Sep;12(9):1782-6.
3
A comparison of two steroid receptor assays in breast cancer: dextran coated charcoal and isoelectric focusing.两种乳腺癌类固醇受体检测方法的比较:葡聚糖包被活性炭法和等电聚焦法。
Anticancer Res. 1983 Jul-Aug;3(4):243-6.
4
Comparison of dextran-coated charcoal and sucrose density gradient analyses of estrogen and progesterone receptors in human breast cancer.人乳腺癌中雌激素和孕激素受体的葡聚糖包被活性炭分析法与蔗糖密度梯度分析法的比较
Cancer Res. 1980 Nov;40(11):4127-32.
5
Immunofluorescent detection of estrogen receptors in breast cancer. Comparison with dextran-coated charcoal and sucrose gradient assays.乳腺癌中雌激素受体的免疫荧光检测。与葡聚糖包被活性炭及蔗糖梯度分析法的比较。
Cancer. 1978 Mar;41(3):907-11. doi: 10.1002/1097-0142(197803)41:3<907::aid-cncr2820410318>3.0.co;2-v.
6
Immunocytochemical demonstration of estrogen receptors by monoclonal antibodies in human breast cancer: correlation with estrogen receptor assay by dextran-coated charcoal method.用单克隆抗体对人乳腺癌雌激素受体进行免疫细胞化学检测:与葡聚糖包被活性炭法雌激素受体检测的相关性
Cancer Res. 1987 May 1;47(9):2508-13.
7
Comparative histochemical and biochemical assays of estrogen receptors in breast cancer patients.
Gan. 1981 Feb;72(1):60-5.
8
Estrogen receptor in very small breast tumor specimens: a modified charcoal-gelatin assay.
Cancer Res. 1986 Jul;46(7):3375-7.
9
Estrogen receptors in human breast cancer: comparative features of the hydroxylapatite- and dextran-coated charcoal assay.人乳腺癌中的雌激素受体:羟基磷灰石和葡聚糖包被活性炭分析法的比较特征
Eur J Cancer Clin Oncol. 1982 Nov;18(11):1075-9. doi: 10.1016/0277-5379(82)90086-4.
10
Estrogen receptors by immunofluorescence: comparison with a dextran coated charcoal technique.雌激素受体的免疫荧光检测:与葡聚糖包被活性炭技术的比较
Ann Clin Lab Sci. 1981 Mar-Apr;11(2):132-7.

引用本文的文献

1
Molecular profiling of advanced malignancies guides first-line N-of-1 treatments in the I-PREDICT treatment-naïve study.先进恶性肿瘤的分子谱分析指导 I-PREDICT 研究中一线 N-of-1 治疗。
Genome Med. 2021 Oct 4;13(1):155. doi: 10.1186/s13073-021-00969-w.
2
Extranuclear signaling by sex steroid receptors and clinical implications in breast cancer.核外信号转导途径在甾体激素受体介导的乳腺癌发生发展中的作用及临床意义
Mol Cell Endocrinol. 2018 May 5;466:51-72. doi: 10.1016/j.mce.2017.11.010. Epub 2017 Nov 14.
3
Prognostic and predictive value of low estrogen receptor expression in breast cancer.
低雌激素受体表达在乳腺癌中的预后及预测价值
Curr Oncol. 2017 Apr;24(2):e106-e114. doi: 10.3747/co.24.3238. Epub 2017 Apr 27.
4
Automated measurement of estrogen receptor in breast cancer: a comparison of fluorescent and chromogenic methods of measurement.乳腺癌中雌激素受体的自动化检测:荧光法与显色法检测的比较
Lab Invest. 2016 Sep;96(9):1016-25. doi: 10.1038/labinvest.2016.73. Epub 2016 Jun 27.
5
Prevalence of HER-2 and Hormone Receptors and P53 Mutations in the Pathologic Specimens of Breast Cancer Patients.乳腺癌患者病理标本中HER-2、激素受体及P53突变的发生率
Int J Breast Cancer. 2014;2014:564308. doi: 10.1155/2014/564308. Epub 2014 Nov 12.
6
Clinical and biologic features of triple-negative breast cancers in a large cohort of patients with long-term follow-up.在一项具有长期随访的大型患者队列中,三阴性乳腺癌的临床和生物学特征。
Breast Cancer Res Treat. 2012 Dec;136(3):795-804. doi: 10.1007/s10549-012-2315-y. Epub 2012 Nov 4.
7
Methylation of HIN-1, RASSF1A, RIL and CDH13 in breast cancer is associated with clinical characteristics, but only RASSF1A methylation is associated with outcome.在乳腺癌中,HIN-1、RASSF1A、RIL 和 CDH13 的甲基化与临床特征相关,但只有 RASSF1A 甲基化与预后相关。
BMC Cancer. 2012 Jun 13;12:243. doi: 10.1186/1471-2407-12-243.
8
Epidermal growth factor receptor expression in breast cancer association with biologic phenotype and clinical outcomes.表皮生长因子受体在乳腺癌中的表达与生物学表型和临床结局的关系。
Cancer. 2010 Mar 1;116(5):1234-42. doi: 10.1002/cncr.24816.
9
Current molecular diagnostics of breast cancer and the potential incorporation of microRNA.乳腺癌的当前分子诊断及微小RNA的潜在纳入
Expert Rev Mol Diagn. 2009 Jul;9(5):455-67. doi: 10.1586/erm.09.25.
10
Prognostic significance of immunoreactive neutrophil elastase in human breast cancer: long-term follow-up results in 313 patients.免疫反应性中性粒细胞弹性蛋白酶在人类乳腺癌中的预后意义:313例患者的长期随访结果
Neoplasia. 2007 Mar;9(3):260-4. doi: 10.1593/neo.06808.